Entia Biosciences, Inc.: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2016)
- $265.5K
- Net Income/Loss (FY2016)
- -$1.4M
- Total Assets (FY2016)
- $439.1K
- Total Equity (FY2016)
- -$2.0M
- Cash Flows from Operating Activities (FY2016)
- -$715.1K
Source: Entia Biosciences, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
